Clinical Scorecard: Clinical Case Study: Hemophagocytic Lymphohistiocytosis Induced by Escherichia coli Invasion of Bone Marrow in a Seronegative Rheumatoid Arthritis Patient Undergoing Low-Dose Methotrexate Therapy

At a Glance

Key Highlights

• HLH can be secondary to infections, such as E. coli urinary tract infections.
• Bone marrow aspiration is essential for diagnosing HLH.
• The presence of hemophagocytes in bone marrow indicates a need for careful evaluation.
• HLH can present with severe pancytopenia and systemic inflammation.
• Empirical antimicrobial therapy is critical in managing suspected HLH cases.

Guideline-Based Recommendations

Diagnosis

• Perform bone marrow aspiration to confirm the presence of hemophagocytic cells.

Management

• Initiate empirical antimicrobial therapy for suspected infections.

Monitoring & Follow-up

• Monitor laboratory parameters including complete blood count and inflammatory markers.

Risks

• Risk of severe immunosuppression and complications from underlying conditions.

Patient & Prescribing Data

Seronegative rheumatoid arthritis patients on low-dose methotrexate.

Methotrexate therapy may contribute to immunosuppression, increasing the risk of infections.

Clinical Best Practices

• Evaluate for HLH in patients with severe systemic inflammation and pancytopenia.
• Consider underlying infections as potential triggers for HLH.

Related Resources & Content

• Clinical Case Study